Sánchez-Sanz, A.; Muñoz-Viana, R.; Sabín-Muñoz, J.; Moreno-Torres, I.; Brea-Álvarez, B.; Rodríguez-De la Fuente, O.; García-Merino, A.; Sánchez-López, A.J.
Response to Fingolimod in Multiple Sclerosis Patients Is Associated with a Differential Transcriptomic Regulation. Int. J. Mol. Sci. 2024, 25, 1372.
https://doi.org/10.3390/ijms25031372
AMA Style
Sánchez-Sanz A, Muñoz-Viana R, Sabín-Muñoz J, Moreno-Torres I, Brea-Álvarez B, Rodríguez-De la Fuente O, García-Merino A, Sánchez-López AJ.
Response to Fingolimod in Multiple Sclerosis Patients Is Associated with a Differential Transcriptomic Regulation. International Journal of Molecular Sciences. 2024; 25(3):1372.
https://doi.org/10.3390/ijms25031372
Chicago/Turabian Style
Sánchez-Sanz, Alicia, Rafael Muñoz-Viana, Julia Sabín-Muñoz, Irene Moreno-Torres, Beatriz Brea-Álvarez, Ofir Rodríguez-De la Fuente, Antonio García-Merino, and Antonio J. Sánchez-López.
2024. "Response to Fingolimod in Multiple Sclerosis Patients Is Associated with a Differential Transcriptomic Regulation" International Journal of Molecular Sciences 25, no. 3: 1372.
https://doi.org/10.3390/ijms25031372
APA Style
Sánchez-Sanz, A., Muñoz-Viana, R., Sabín-Muñoz, J., Moreno-Torres, I., Brea-Álvarez, B., Rodríguez-De la Fuente, O., García-Merino, A., & Sánchez-López, A. J.
(2024). Response to Fingolimod in Multiple Sclerosis Patients Is Associated with a Differential Transcriptomic Regulation. International Journal of Molecular Sciences, 25(3), 1372.
https://doi.org/10.3390/ijms25031372
